Fair Accounting for Income Realized from Betting Earnings Taxation Act

House Bill

H.R. 4304

119th Congress

Fair Accounting for Income Realized from Betting Earnings Taxation Act

In Committee

Introduced:Jul 10, 2025

Primary Sponsor

Dina Titus

Representative

Democratic

NV-1

Cosponsors

4

Quick Stats

Policy Area

Health

Summary

This bill would remove pancreatic islets (groups of cells, including those that make insulin) donated from human cadavers from being regulated as a drug or biological product by the Food and Drug Administration (FDA). Instead, it would treat these islets as organs, which means they would be subject to the regulatory framework that governs organ donation and transplantation.

Latest Action

Referred to the Subcommittee on Health.

SponsorDina Titus (D-NV)

Introduced7/10/2025

StatusReferred to the House Committee on Ways and Means.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Fair Accounting for Income Realized from Betting Earnings Taxation Act

This bill would remove pancreatic islets (groups of cells, including those that make insulin) donated from human cadavers from being regulated as a drug or biological product by the Food and Drug Administration (FDA). Instead, it would treat these islets as or

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would remove pancreatic islets (groups of cells, including those that make insulin) donated from human cadavers from being regulated as a drug or biological product by the Food and Drug Administration (FDA). Instead, it would treat these islets as organs, which means they would be subject to the regulatory framework that governs organ donation and transplantation.

Bill Number: 4304
Sponsor: Dina Titus (D-NV)
Introduced: 7/10/2025
Status: Referred to the House Committee on Ways and Means.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Fair Accounting for Income Realized from Betting Earnings Taxation Act
Bill Number: 4304
Sponsor: Dina Titus (D-NV)
Status: Referred to the House Committee on Ways and Means.
Introduced: 7/10/2025
Summary: This bill would remove pancreatic islets (groups of cells, including those that make insulin) donated from human cadavers from being regulated as a drug or biological product by the Food and Drug Administration (FDA). Instead, it would treat these islets as organs, which means they would be subject

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would remove pancreatic islets (groups of cells, including those that make insulin) donated from human cadavers from being regulated as a drug or biological product by the Food and Drug Administration (FDA). Instead, it would treat these islets as organs, which means they would be subject to the regulatory framework that governs organ donation and transplantation.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

<html><body bgcolor="#FFFFFF">Increase Support for Life-saving Endocrine Transplantation Act or the ISLET Act This bill removes pancreatic islets that are donated from human cadavers from regulation as a drug or biological product by the Food and Drug Administration (FDA). (Islets are groups of cells, including those that make insulin, in the pancreas, and islet transplantation is an experimental treatment for certain conditions, such as type 1 diabetes.) Current FDA guidance treats pancreatic islets as a biological product, which makes them subject to the biological license application process and related standards for manufacturing practices, safety, identity, purity, and potency. The bill, instead, treats human cadaveric islets as organs, which makes them subject to the regulatory framework that governs the allocation, safety, and efficacy of organ donation and transplantation. That framework, developed by the Health Resources and Services Administration, is carried out by contract through the Organ Procurement and Transplantation Network. (The network is a public-private partnership that links the professionals involved in the U.S. donation and transplantation system.) Specifically, the bill defines human cadaveric islets as organs and excludes them from definitions related to the regulation of drugs and biological products.</body></html>

Key Points

Main provisions of the bill

Removes pancreatic islets donated from human cadavers from FDA regulation as a drug or biological product
Treats these islets as organs, subject to the regulatory framework for organ donation and transplantation
Aims to make it easier for patients to access this experimental treatment for conditions like type 1 diabetes

How This Impacts Americans

Potential effects on citizens and communities

If this bill becomes law, it could increase access to islet transplantation, which is an experimental treatment for certain conditions like type 1 diabetes. Patients in need of this treatment could potentially benefit, as the regulatory burden would be reduced. Healthcare providers who perform these transplants would also be impacted, as they would have to follow the organ donation and transplantation framework instead of the stricter drug/biological product regulations.

Policy Areas

Primary Policy Area

Health

Related Subjects

Administrative law and regulatory procedures

Congressional oversight

Department of Health and Human Services

Digestive and metabolic diseases

Organ and tissue donation and transplantation

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

4304, 119th Congress (2025). "Fair Accounting for Income Realized from Betting Earnings Taxation Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-4304